EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.41%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.55B
AUM Growth
+$502M
(+9.9%)
Cap. Flow
+$203M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
934
New
51
Increased
198
Reduced
144
Closed
33
Top Buys
| 1 |
Cintas
CTAS
|
+$23.7M |
| 2 |
Sunrun
RUN
|
+$18.3M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$14.6M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
+$14M |
| 5 |
Home Depot
HD
|
+$13.5M |
Top Sells
| 1 |
Silicon Motion
SIMO
|
+$25.9M |
| 2 |
NVIDIA
NVDA
|
+$25.7M |
| 3 |
Visa
V
|
+$16.9M |
| 4 |
Comcast
CMCSA
|
+$16.5M |
| 5 |
TJX Companies
TJX
|
+$14.5M |
Sector Composition
| 1 | Technology | 31.13% |
| 2 | Healthcare | 18.95% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Financials | 9.3% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Citizens Financial Group
CFG
$22.3B
| $343K | 0.01% |
+7,247
| New | +$343K |
|
452
Charter Communications
CHTR
$36B
| $342K | 0.01% |
+521
| New | +$342K |
|
453
Vaxcyte
PCVX
$4.21B
| $341K | 0.01% |
14,200
| – | – |
|
454
Invesco
IVZ
$9.81B
| $337K | 0.01% |
+14,414
| New | +$337K |
|
|
ADAP
455
Adaptimmune Therapeutics
ADAP
$13M
| $333K | 0.01% |
90,000
| – | – |
|
456
AGCO
AGCO
$8.23B
| $331K | 0.01% |
+2,855
| New | +$331K |
|
457
West Fraser Timber
WFG
$6.01B
| $319K | 0.01% |
3,350
| – | – |
|
458
Replimune Group
REPL
$454M
| $318K | 0.01% |
11,900
| – | – |
|
459
Keros Therapeutics
KROS
$628M
| $318K | 0.01% |
5,700
| – | – |
|
460
PVH
PVH
$4.07B
| $317K | 0.01% |
+3,000
| New | +$317K |
|
461
Sangamo Therapeutics
SGMO
$157M
| $301K | 0.01% |
38,000
| – | – |
|
462
Afya
AFYA
$1.42B
| $293K | 0.01% |
19,191
-6,250
| -25% | -$95.5K |
|
463
MacroGenics
MGNX
$111M
| $286K | 0.01% |
18,000
| – | – |
|
464
Lincoln National
LNC
$7.9B
| $282K | 0.01% |
4,100
-2,200
| -35% | -$151K |
|
465
American Financial Group
AFG
$11.5B
| $278K | 0.01% |
2,000
-1,700
| -46% | -$236K |
|
|
CMRX
466
DELISTED
Chimerix, Inc.
CMRX
| $270K | ﹤0.01% |
+40,000
| New | +$270K |
|
467
Scholar Rock
SRRK
$3.04B
| $266K | ﹤0.01% |
10,300
| – | – |
|
468
Assurant
AIZ
$10.7B
| $263K | ﹤0.01% |
1,700
-700
| -29% | -$108K |
|
|
PSTH
469
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $261K | ﹤0.01% |
13,250
+600
| +5% | +$11.8K |
|
470
Fair Isaac
FICO
$36.9B
| $260K | ﹤0.01% |
600
| – | – |
|
471
Markel Group
MKL
$24.4B
| $248K | ﹤0.01% |
200
-200
| -50% | -$248K |
|
472
W.R. Berkley
WRB
$27.5B
| $248K | ﹤0.01% |
6,750
-11,430
| -63% | -$419K |
|
473
Arcturus Therapeutics
ARCT
$484M
| $241K | ﹤0.01% |
6,200
| – | – |
|
474
Seres Therapeutics
MCRB
$163M
| $235K | ﹤0.01% |
1,350
| – | – |
|
475
Arcutis Biotherapeutics
ARQT
$2.15B
| $227K | ﹤0.01% |
11,100
| – | – |
|